Send the following on WhatsApp
Continue to ChatU.S. Halts Distribution of Lilly’s Bamlanivimab Monotherapy, Citing SARS-CoV-2 Variant Resistance https://invesbrain.com/u-s-halts-distribution-of-lillys-bamlanivimab-monotherapy-citing-sars-cov-2-variant-resistance/